2181 - 2190 of 7915 Results
Title
Year
-
OPENTitle: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 34Issue #:Start Page: 103022End Page: 103022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103022Citation Count: 15
-
OPENTitle: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune functionJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110090End Page: 110090Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090Best OA location URL: http://www.cell.com/article/S2211124721015813/pdfCitation Count: 68
- An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration2022RESTRICTEDTitle: An atypical ubiquitin ligase at the heart of neural development and programmed axon degenerationJournal Name: Neural Regeneration ResearchPublisher: MedknowVol: 17Issue #: 11Start Page: 2347End Page: 2347Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.4103/1673-5374.338992Best OA location URL: https://doi.org/10.4103/1673-5374.338992Citation Count: 8
-
OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: http://www.prd-journal.com/article/S135380202100434X/pdfCitation Count: 4
- Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases2022RESTRICTEDTitle: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 1Start Page: 101478End Page: 101478Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478Best OA location URL: http://www.jbc.org/article/S0021925821012874/pdfCitation Count: 19
-
OPENTitle: Association between cigarette smoking and Parkinson’s disease: a neuroimaging studyJournal Name: Therapeutic Advances in Neurological DisordersPublisher: SAGE PublicationsVol: 15Issue #:Start Page: 175628642210925End Page: 175628642210925Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/17562864221092566Best OA location URL: https://doi.org/10.1177/17562864221092566Citation Count: 20
-
OPENTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://doi.org/10.1002/trc2.12255Citation Count: 25
-
OPENTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related ResearchJournal Name: The Journal Of Prevention of Alzheimer's DiseasePublisher: SERDIVol:Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 1
-
OPENTitle: Auto-annotating sleep stages based on polysomnographic dataJournal Name: PatternsPublisher: Elsevier BVVol: 3Issue #: 1Start Page: 100371End Page: 100371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.patter.2021.100371Best OA location URL: http://www.cell.com/article/S2666389921002336/pdfCitation Count: 17
- c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities2022RESTRICTEDTitle: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and OpportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28907Citation Count: 3